HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.
Current candidate vaccines fail to protect primates against challenge with human immunodeficiency virus (HIV) in the presence of antibody responses; this underlines the importance of studying cell-mediated immunity to HIV and identifying specific epitopes that stimulate cytotoxic T lymphocytes (CTL)...
主要な著者: | Nixon, D, Townsend, A, Elvin, J, Rizza, C, Gallwey, J, Mcmichael, A |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
1988
|
類似資料
-
HIV-gag-specific cytotoxic T lymphocytes.
著者:: Nixon, D, 等
出版事項: (1989) -
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.
著者:: Townsend, A, 等
出版事項: (1986) -
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides
著者:: Townsend, A, 等
出版事項: (1986) -
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. 1986.
著者:: Townsend, A, 等
出版事項: (2006) -
Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro.
著者:: Dorrell, L, 等
出版事項: (2000)